{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:44:21Z","timestamp":1792799061354,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Neuroradiol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is a\u00a0rare neuromuscular disease treated with intrathecal nusinersen. In patients with complex spinal anatomy or spinal instrumentation, repeated lumbar punctures can be challenging. This study evaluated the feasibility, safety, and radiation exposure of CT-guided nusinersen administration in SMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-center study, 458 CT-guided nusinersen injections in 44\u00a0SMA patients (October 2017\u2013August 2024) were analyzed. Technical success, complications, procedure and puncture times, and radiation exposure were compared between subgroups. Procedures were performed in prone, lateral, or combined (oblique) positions depending on anatomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Technical success was 98.3% (449\/458). Rates were slightly lower in patients with dorsal spondylodesis (97.1% vs. 98.8%). Complications occurred in 1.1% (5\/458), including transient pain and two hematomas. Spondylodesis was associated with longer puncture (11.9 vs. 10.3\u202fmin) and procedure durations (16.3 vs. 14.0\u202fmin) and higher radiation doses (effective dose 2.22 vs. 1.74\u202fmSv; all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&lt;\u20090.01). Failed or complicated procedures showed prolonged durations and higher exposure. Needle repositioning correlated with duration and dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CT-guided lumbar puncture for intrathecal nusinersen injection is a\u00a0safe and effective technique, even in complex spinal anatomy. Dorsal spondylodesis increases procedural complexity. Tailored puncture level selection, optimized positioning, and dose-reduction strategies are essential for high success rates and minimal radiation. While CT guidance ensures excellent anatomical visualization, fluoroscopy may reduce radiation and procedure time; future comparative studies should define optimal modality selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00062-025-01590-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:56:13Z","timestamp":1764060973000},"page":"401-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CT-guided Lumbar Puncture for Intrathecal Nusinersen Injection in Patients with Spinal Muscular Atrophy: Technical Effectiveness, Safety, and Radiation Dose"],"prefix":"10.1007","volume":"36","author":[{"given":"Yannick Laurent","family":"Thal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Ocker-Serger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Valentina","family":"Kl\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Alexander","family":"Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haubold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hagenacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"5","key":"1590_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri\u00a0E, Bertini\u00a0E, Iannaccone\u00a0ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(12)70061-3.","journal-title":"Lancet Neurol"},{"issue":"23","key":"1590_CR2","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale\u00a0S, Pellizzoni\u00a0L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J\u00a0Neurosci. 2015;35(23):8691\u2013700. https:\/\/doi.org\/10.1523\/JNEUROSCI.0417-15.2015.","journal-title":"J Neurosci"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","volume":"14","author":"MC Keinath","year":"2021","unstructured":"Keinath\u00a0MC, Prior\u00a0DE, Prior\u00a0TW. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl Clin Genet. 2021;14:11\u201325. https:\/\/doi.org\/10.2147\/TACG.S239603. 25.","journal-title":"Appl Clin Genet"},{"issue":"15","key":"1590_CR4","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.3390\/ijms22157896","volume":"22","author":"Butchbach MER","year":"2021","unstructured":"Butchbach MER. Genomic variability in the survival motor neuron genes (SMN1 and SMN\u00a02): implications for spinal muscular atrophy phenotype and therapeutics development. Int J Mol Sci. 2021;22(15):7896. https:\/\/doi.org\/10.3390\/ijms22157896.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1590_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre\u00a0S, Burlet\u00a0P, Liu\u00a0Q, Bertrandy\u00a0S, Clermont\u00a0O, Munnich\u00a0A, et\u00a0al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997;16(3):265\u20139. https:\/\/doi.org\/10.1038\/ng0797-265.","journal-title":"Nat Genet"},{"issue":"2","key":"1590_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter\u00a0M, Schwarzer\u00a0V, Wirth\u00a0R, Wienker\u00a0TF, Wirth\u00a0B. Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70(2):358\u201368. https:\/\/doi.org\/10.1086\/338627.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1590_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre\u00a0S, B\u00fcrglen\u00a0L, Reboullet\u00a0S, Clermont\u00a0O, Burlet\u00a0P, Viollet\u00a0L, et\u00a0al. Identification and characterization of a\u00a0spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3.","journal-title":"Cell"},{"issue":"11","key":"1590_CR8","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/molecules29112658","volume":"29","author":"J Leckie","year":"2024","unstructured":"Leckie\u00a0J, Yokota\u00a0T. Potential of cell-penetrating peptide-conjugated Antisense Oligonucleotides for the treatment of SMA. Molecules. 2024;29(11):2658. https:\/\/doi.org\/10.3390\/molecules29112658.","journal-title":"Molecules"},{"issue":"12","key":"1590_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s40263-021-00889-8","volume":"35","author":"SM Hoy","year":"2021","unstructured":"Hoy\u00a0SM. Nusinersen: a\u00a0review in 5q spinal muscular atrophy. CNS Drugs. 2021;35(12):1317\u201328. https:\/\/doi.org\/10.1007\/s40263-021-00889-8.","journal-title":"CNS Drugs"},{"issue":"10063","key":"1590_CR10","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel\u00a0RS, Chiriboga\u00a0CA, Vajsar\u00a0J, Day\u00a0JW, Montes\u00a0J, De Vivo\u00a0DC, et\u00a0al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a\u00a0phase\u00a02, open-label, dose-escalation study. Lancet. 2016;388(10063):3017\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8.","journal-title":"Lancet"},{"issue":"4","key":"1590_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","volume":"19","author":"T Hagenacker","year":"2020","unstructured":"Hagenacker\u00a0T, Wurster\u00a0CD, G\u00fcnther\u00a0R, Schreiber-Katz\u00a0O, Osmanovic\u00a0A, Petri\u00a0S, Weiler\u00a0M, et\u00a0al. Nusinersen in adults with 5q spinal muscular atrophy: a\u00a0non-interventional, multicentre, observational cohort study. Lancet Neurol. 2020;19(4):317\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(20)30037-5.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1590_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s40120-024-00653-2","volume":"13","author":"T Hagenacker","year":"2024","unstructured":"Hagenacker\u00a0T, Maggi\u00a0L, Coratti\u00a0G, Youn\u00a0B, Raynaud\u00a0S, Paradis\u00a0AD, Mercuri\u00a0E. Effectiveness of Nusinersen in adolescents and adults with spinal muscular atrophy: systematic review and meta-analysis. Neurol Ther. 2024;13(5):1483\u2013504. https:\/\/doi.org\/10.1007\/s40120-024-00653-2.","journal-title":"Neurol Ther"},{"key":"1590_CR13","doi-asserted-by":"publisher","first-page":"175628641880324","DOI":"10.1177\/1756286418803246","volume":"11","author":"B Stolte","year":"2018","unstructured":"Stolte\u00a0B, Totzeck\u00a0A, Kizina\u00a0K, Bolz\u00a0S, Pietruck\u00a0L, M\u00f6nninghoff\u00a0C, et\u00a0al. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. Ther Adv Neurol Disord. 2018;11:1756286418803246. https:\/\/doi.org\/10.1177\/1756286418803246.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1590_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejpn.2017.11.001","volume":"22","author":"A Pechmann","year":"2018","unstructured":"Pechmann\u00a0A, Langer\u00a0T, Wider\u00a0S, Kirschner\u00a0J. Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type\u00a01. Eur J Paediatr Neurol. 2018;22(1):122\u20137. https:\/\/doi.org\/10.1016\/j.ejpn.2017.11.001.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"1590_CR15","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","volume":"93","author":"CA Wijngaarde","year":"2019","unstructured":"Wijngaarde\u00a0CA, Brink\u00a0RC, de Kort\u00a0FAS, Stam\u00a0M, Otto\u00a0LAM, Asselman\u00a0FL, et\u00a0al. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy. Neurology. 2019;93(2):e149\u2013e58. https:\/\/doi.org\/10.1212\/WNL.0000000000007742.","journal-title":"Neurology"},{"key":"1590_CR16","doi-asserted-by":"publisher","first-page":"175628641988761","DOI":"10.1177\/1756286419887616","volume":"13","author":"I Cordts","year":"2020","unstructured":"Cordts\u00a0I, Lingor\u00a0P, Friedrich\u00a0B, Pernpeintner\u00a0V, Zimmer\u00a0C, Deschauer\u00a0M, Maegerlein\u00a0C. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy. Ther Adv Neurol Disord. 2020;13:1756286419887616. https:\/\/doi.org\/10.1177\/1756286419887616.","journal-title":"Ther Adv Neurol Disord"},{"key":"1590_CR17","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1016\/j.pediatrneurol.2022.04.008","volume":"132","author":"E Madan","year":"2022","unstructured":"Madan\u00a0E, Carri\u00e9\u00a0S, Donado\u00a0C, Lobo\u00a0K, Souris\u00a0M, Laine\u00a0R, et\u00a0al. Nusinersen for patients with spinal muscular atrophy: 1415 doses via an interdisciplinary institutional approach. Pediatr Neurol. 2022;132:3340. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2022.04.008.","journal-title":"Pediatr Neurol"},{"key":"1590_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2008.07.001","volume":"37","author":"International Commission on Radiological Protection","year":"2007","unstructured":"International Commission on Radiological Protection. The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP. 2007;37:1\u2013332. https:\/\/doi.org\/10.1016\/j.icrp.2008.07.001.","journal-title":"Ann ICRP"},{"issue":"1","key":"1590_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","volume":"266","author":"CD Wurster","year":"2019","unstructured":"Wurster\u00a0CD, Winter\u00a0B, Wollinsky\u00a0K, Ludolph\u00a0AC, Uzelac\u00a0Z, Witzel\u00a0S, et\u00a0al. Intrathecal administration of nusinersen in adolescent and adult SMA type\u00a02 and\u00a03\u00a0patients. J\u00a0Neurol. 2019;266(1):183\u201394. https:\/\/doi.org\/10.1007\/s00415-018-9124-0.","journal-title":"J Neurol"},{"issue":"1","key":"1590_CR20","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1038\/s41598-020-60240-x","volume":"10","author":"I Cordts","year":"2020","unstructured":"Cordts\u00a0I, Deschauer\u00a0M, Lingor\u00a0P, Burian\u00a0E, Baum\u00a0T, Zimmer\u00a0C, et\u00a0al. Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy. Sci Rep. 2020;10(1):3406. https:\/\/doi.org\/10.1038\/s41598-020-60240-x.","journal-title":"Sci Rep"},{"issue":"12","key":"1590_CR21","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00247-018-4206-9","volume":"48","author":"MA Mousa","year":"2018","unstructured":"Mousa\u00a0MA, Aria\u00a0DJ, Schaefer\u00a0CM, Kaye\u00a0RD, Abruzzo\u00a0TA, Bernes\u00a0SM, et\u00a0al. A\u00a0comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy. Pediatr Radiol. 2018;48(12):1797\u2013805. https:\/\/doi.org\/10.1007\/s00247-018-4206-9.","journal-title":"Pediatr Radiol"},{"issue":"2","key":"1590_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1590\/0004-282X-ANP-2020-0200","volume":"79","author":"RH Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a\u00a0RH, Fernandes\u00a0HDS, Pinto\u00a0RBS, Matsui\u00a0JC, Polido\u00a0GJ, Silva\u00a0AMSD, et\u00a0al. Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery. Arq Neuropsiquiatr. 2021;79(2):127\u201332. https:\/\/doi.org\/10.1590\/0004-282X-ANP-2020-0200.","journal-title":"Arq Neuropsiquiatr"},{"key":"1590_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fneur.2019.01166","volume":"10","author":"K Kizina","year":"2019","unstructured":"Kizina\u00a0K, Stolte\u00a0B, Totzeck\u00a0A, Bolz\u00a0S, Fleischer\u00a0M, M\u00f6nninghoff\u00a0C, et\u00a0al. Clinical implication of dosimetry of computed Tomography- and fluoroscopy-guided Intrathecal therapy with Nusinersen in adult patients with spinal muscular atrophy. Front Neurol. 2019;10:1166. https:\/\/doi.org\/10.3389\/fneur.2019.01166.","journal-title":"Front Neurol"},{"issue":"7","key":"1590_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/ene.14245","volume":"27","author":"S Spiliopoulos","year":"2020","unstructured":"Spiliopoulos\u00a0S, Reppas\u00a0L, Zompola\u00a0C, Palaiodimou\u00a0L, Papadopoulou\u00a0M, Filippiadis\u00a0D, et\u00a0al. Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type\u00a02 and severe spinal deformity. Feasibility, safety and radiation exposure considerations. Eur J Neurol. 2020;27(7):1343\u20139. https:\/\/doi.org\/10.1111\/ene.14245.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1590_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/neurintsurg-2020-016058","volume":"13","author":"JJ Weaver","year":"2021","unstructured":"Weaver\u00a0JJ, Hallam\u00a0DK, Chick\u00a0JFB, Vaidya\u00a0S, Shin\u00a0DS, Natarajan\u00a0N, Rad\u00a0N, et\u00a0al. Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections. J\u00a0Neurointerv Surg. 2021;13(1):75\u20138. https:\/\/doi.org\/10.1136\/neurintsurg-2020-016058.","journal-title":"J Neurointerv Surg"},{"issue":"8","key":"1590_CR26","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3174\/ajnr.A6131","volume":"40","author":"R Towbin","year":"2019","unstructured":"Towbin\u00a0R, Schaefer\u00a0C, Kaye\u00a0R, Abruzzo\u00a0T, Aria\u00a0DJ. The complex spine in children with spinal muscular atrophy: the Transforaminal approach\u2014A Transformative technique. Ajnr Am J Neuroradiol. 2019;40(8):1422\u20136. https:\/\/doi.org\/10.3174\/ajnr.A6131.","journal-title":"Ajnr Am J Neuroradiol"},{"key":"1590_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420907803","author":"E Jochmann","year":"2020","unstructured":"Jochmann\u00a0E, Steinbach\u00a0R, Jochmann\u00a0T, Chung\u00a0HY, R\u00f6diger\u00a0A, Neumann\u00a0R, et\u00a0al. Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen. Ther Adv Neurol Disord. 2020; https:\/\/doi.org\/10.1177\/1756286420907803. 1756286420907803.","journal-title":"Ther Adv Neurol Disord"},{"key":"1590_CR28","doi-asserted-by":"publisher","first-page":"105336","DOI":"10.1016\/j.nmd.2025.105336","volume":"49","author":"S Lando-Dotan","year":"2025","unstructured":"Lando-Dotan\u00a0S, et\u00a0al. Fluoroscopic guidance for intrathecal delivery of nusinersen in pediatric patients with spinal muscular atrophy and complex spines. Neuromuscul Disord. 2025;49:105336. https:\/\/doi.org\/10.1016\/j.nmd.2025.105336.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1590_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1590\/0004-282X-ANP-2020-0200","volume":"79","author":"RH Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a\u00a0RH, Fernandes\u00a0HDS, Pinto\u00a0RBS, Matsui\u00a0JC, Polido\u00a0GJ, Silva\u00a0AMSD, et\u00a0al. Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery. Arq Neuropsiquiatr. 2021;79(2):127\u201332. https:\/\/doi.org\/10.1590\/0004-282X-ANP-2020-0200.","journal-title":"Arq Neuropsiquiatr"},{"key":"1590_CR30","doi-asserted-by":"crossref","unstructured":"Bevelacqua JJ. Practical and effective ALARA. Health Phys.98(2):S39\u2013S47.","DOI":"10.1097\/HP.0b013e3181d18d63"},{"key":"1590_CR31","doi-asserted-by":"publisher","unstructured":"Prasad KN, Cole WC, Haase GM. Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. Br J Radiol.77:97\u20139. https:\/\/doi.org\/10.1259\/bjr\/88081058.","DOI":"10.1259\/bjr\/88081058"},{"issue":"5","key":"1590_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00234-019-02189-x","volume":"61","author":"D Oldenburg","year":"2019","unstructured":"Oldenburg\u00a0D, Guberina\u00a0N, Stolte\u00a0B, Kizina\u00a0K, Stenzel\u00a0E, et\u00a0al. Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy. Neuroradiology. 2019;61(5):565\u201374. https:\/\/doi.org\/10.1007\/s00234-019-02189-x.","journal-title":"Neuroradiology"},{"issue":"7","key":"1590_CR33","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1212\/WNL.0000000000006006","volume":"91","author":"A Veerapandiyan","year":"2018","unstructured":"Veerapandiyan\u00a0A, Pal\u00a0R, D\u2019Ambrosio\u00a0S, Young\u00a0I, Eichinger\u00a0K, Collins\u00a0E, Westesson\u00a0PL, Kwon\u00a0J, Ciafaloni\u00a0E. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy. Neurology. 2018;91(7):e620\u2013e4. https:\/\/doi.org\/10.1212\/WNL.0000000000006006.","journal-title":"Neurology"},{"issue":"1","key":"1590_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-023-02630-8","volume":"18","author":"C Wei","year":"2023","unstructured":"Wei\u00a0C, Liang\u00a0Z, Wu\u00a0Y, Liu\u00a0S, Qiu\u00a0J, Meng\u00a0L, et\u00a0al. Ultrasound-guided interlaminar approach for nusinersen administration in patients with spinal muscular atrophy with spinal fusion or severe scoliosis. Orphanet J Rare Dis. 2023;18(1):30. https:\/\/doi.org\/10.1186\/s13023-023-02630-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1590_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00247-018-4240-7","volume":"49","author":"CB Ortiz","year":"2019","unstructured":"Ortiz\u00a0CB, Kukreja\u00a0KU, Lotze\u00a0TE, Chau\u00a0A. Ultrasound-guided cervical puncture for nusinersen administration in adolescents. Pediatr Radiol. 2019;49(1):136\u201340. https:\/\/doi.org\/10.1007\/s00247-018-4240-7.","journal-title":"Pediatr Radiol"}],"container-title":["Clinical Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-025-01590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00062-025-01590-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-025-01590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:00:04Z","timestamp":1782860404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00062-025-01590-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s00062-025-01590-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7722326\/v1","asserted-by":"object"}]},"ISSN":["1869-1439","1869-1447"],"issn-type":[{"value":"1869-1439","type":"print"},{"value":"1869-1447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Thal, M. Opitz, R. Ocker-Serger, L. Kl\u00fcner, D. Rosok, M. Drews, D. Bos, J. Haubold, C. Kleinschnitz, T. Hagenacker, M. Forsting, C. Deuschl and S. Zensen declare that there are no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}